These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. Weber MA, Stokes GS, Gain JM. J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950 [Abstract] [Full Text] [Related]
25. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS, Gaul SL, Reitz PM, Blaine EH, Ribeiro LT. J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [Abstract] [Full Text] [Related]
26. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats. Waeber B, Gavras H, Gavras I, Chao P, Kohlman O, Bresnahan MR, Brunner HR, Vaughan D. J Pharmacol Exp Ther; 1982 Nov; 223(2):510-5. PubMed ID: 6752375 [Abstract] [Full Text] [Related]
29. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. Geyskes GG, Boer P, Vos J, Leenen FH, Mees EJ. Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756 [Abstract] [Full Text] [Related]
32. Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats. Shudo C, Masuda Y, Sakai T, Tanaka S, Shigenobu K, Kasuya Y. J Pharm Pharmacol; 1993 Jun; 45(6):525-9. PubMed ID: 8103100 [Abstract] [Full Text] [Related]
33. Effect of propranolol on blood pressure and renin in renal hypertension in the rat. Fernandes M, Onesti G, Fiorentini R, Gould AB, Kim KE, Swartz C. Clin Sci Mol Med; 1977 Jan; 52(1):107-9. PubMed ID: 606459 [Abstract] [Full Text] [Related]
35. Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats. Kato Y, Tanaka H, Saijyo T, Hattori O, Suzuki K, Hara T, Deguchi T. J Toxicol Sci; 1993 Aug; 18 Suppl 3():21-31. PubMed ID: 7505033 [Abstract] [Full Text] [Related]
36. [High dose betablocker treatment in experimental renal hypertension (author's transl)]. Girndt J. Klin Wochenschr; 1979 Aug 01; 57(15):793-5. PubMed ID: 40062 [Abstract] [Full Text] [Related]
37. Relation of plasma renin activity to the antihypertensive effect of MK 421 in the rat. Bradshaw D, Franz PH, Sugden AL. Br J Pharmacol; 1982 May 01; 76(1):163-8. PubMed ID: 6282372 [Abstract] [Full Text] [Related]
38. The role of vascular protein and renin in chronic two-kidney, one clip Goldblatt hypertension. Nakada T, Yamori Y. Clin Exp Hypertens A; 1982 May 01; 4(3):477-97. PubMed ID: 7042132 [Abstract] [Full Text] [Related]
39. Lack of antihypertensive effects of chronic administration of DL-propranolol in Grollman rats. Menard J, Alexandre JM, Giudicelli JF, Auzan C, Chevillard C. Arch Int Pharmacodyn Ther; 1973 Apr 01; 202(2):298-303. PubMed ID: 4694367 [No Abstract] [Full Text] [Related]